The landscape of global research and development is undergoing a seismic shift, as the boundary between Silicon Valley’s technology giants…
Read More
As 59% fewer pharma companies cut staff in Q2 in 2026, job postings rise 15%
The biopharmaceutical landscape, which has been characterized by aggressive retrenchment and workforce volatility since 2022, is showing tentative signs of…
Read More
Novo Nordisk’s ziltivekimab misses Phase 3 primary endpoint
In a significant setback for Novo Nordisk’s ambitions to diversify its cardiovascular pipeline, the company announced that its investigational human…
Read More
HHS seeks nominees for vaccine advisory panel with $757K estimated annual cost after almost two years without a meeting
The United States Department of Health and Human Services (HHS) has officially issued a formal solicitation for nominations to the…
Read More
Metabolic stability: The defining challenge for multifunctional peptides
The pharmaceutical landscape is currently undergoing a structural metamorphosis, driven by the unprecedented clinical and commercial success of glucagon-like peptide-1…
Read More
FDA logs more than 1,700 adverse event reports involving compounded semaglutide and tirzepatide
The rapid proliferation of compounded versions of high-demand GLP-1 receptor agonists has reached a critical inflection point, as the U.S.…
Read More
Before its recent Phase 3 LSD win, Definium modeled up to $70,000 a year for a therapy that could fill a clinical shift
New York City-based biotechnology firm Definium Therapeutics has reached a pivotal juncture in the development of its flagship psychedelic candidate,…
Read More
FDA greenlights ViiV’s Tivicay PD for HIV-positive newborns in first month of life
A History of Pediatric Antiretroviral Evolution The journey toward this approval reflects a decade of clinical progress in pediatric HIV…
Read More
Tufts model estimates 82x ROI and up to $21 million in value from Medable AI agent
The integration of artificial intelligence into the pharmaceutical industry has reached a critical inflection point, moving beyond theoretical experimentation into…
Read More
As the dream of the autonomous clinical trial dawns, agent supervision is today’s human job
The landscape of modern drug development is currently undergoing a radical structural shift, characterized by an unprecedented explosion in the…
Read More
